Chilton Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105K Buy
1,637
+1,221
+294% +$80.3K ﹤0.01% 275
2026
Q1
$29.6K Sell
416
-795
-66% -$62.7K ﹤0.01% 382
2025
Q4
$99.3K Sell
1,211
-39
-3% -$3.04K ﹤0.01% 291
2025
Q3
$93.9K Buy
1,250
+23
+2% +$1.72K ﹤0.01% 303
2025
Q2
$90.9K Hold
1,227
﹤0.01% 282
2025
Q1
$99K Hold
1,227
﹤0.01% 267
2024
Q4
$95.9K Hold
1,227
﹤0.01% 276
2024
Q3
$115K Hold
1,227
﹤0.01% 269
2024
Q2
$95.6K Hold
1,227
﹤0.01% 293
2024
Q1
$112K Hold
1,227
0.01% 278
2023
Q4
$94.9K Buy
1,227
+164
+15% +$11.5K ﹤0.01% 297
2023
Q3
$72.3K Hold
1,063
﹤0.01% 291
2023
Q2
$86.4K Hold
1,063
﹤0.01% 284
2023
Q1
$87.2K Buy
+1,063
New +$75.9K 0.01% 293

Other funds holding GEHC

Chilton Capital Management's GEHC Position: Q2 2026 in Review

Chilton Capital Management increased its GE HealthCare (GEHC) stake by 294% in Q2 2026, buying an estimated $80.3K and bringing the position to 1,637 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #275.

Chilton Capital Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $115K in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Chilton Capital Management held 1,637 shares of GE HealthCare worth $105K as of Q2 2026.
  • Chilton Capital Management bought 1,221 GE HealthCare shares in Q2 2026, an estimated $80.3K.
  • GE HealthCare made up ﹤0.01% of Chilton Capital Management's portfolio in Q2 2026, its #275 holding.
  • Chilton Capital Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Chilton Capital Management's GE HealthCare position peaked at $115K in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.